Prothena | Операционный Доход


Operating Profit Изменить
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Akebia Therapeutics AKBA:US $ 52.5M 111M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Biogen BIIB:US $ -59.1M 669.8M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Exelixis EXEL:US $ 83.71M 0.46M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Intra Cellular Therapies ITCI:US $ -87.92M 15.26M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Macrogenics MGNX:US $ -41808000 24.83M
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Prothena PRTA:US -43209000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
Vertex Pharmaceuticals VRTX:US $ 1106.3M 65.4M
Vital Therapies VTL:US $ -20.61M 0.82M
Xoma XOMA:US $ -4767000 2.7M
YTE INCY:US $ 254.43M 137.89M



Prothena Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Aug 2022.